Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Penther

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|January 11, 2020
B-ALL With t(5;14)(q31;q32); <i>IGH-IL3</i> Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar <i>IGH</i>-Rearranged B-ALLBenjamin Fournier, Estelle Balducci, Nicolas Duployez, et al.
Blood|February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique studyEtienne Coyaud, Stephanie Struski, Nais Prade, et al.
American Journal of Hematology|December 2, 2017
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gainElise Chapiro, Claude Lesty, Clémentine Gabillaud, et al.
Blood Advances|October 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Pierre-Julien Viailly, Fanny Drieux, et al.
Leukemia|March 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemiaLoïc Vasseur, Matthieu Duchmann, Nicolas Duployez, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Blood|April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasmsAnouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
NEJM Evidence|June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML TherapyMathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|January 11, 2020
B-ALL With t(5;14)(q31;q32); <i>IGH-IL3</i> Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar <i>IGH</i>-Rearranged B-ALLBenjamin Fournier, Estelle Balducci, Nicolas Duployez, et al.
Blood|February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique studyEtienne Coyaud, Stephanie Struski, Nais Prade, et al.
American Journal of Hematology|December 2, 2017
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gainElise Chapiro, Claude Lesty, Clémentine Gabillaud, et al.
Blood Advances|October 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Pierre-Julien Viailly, Fanny Drieux, et al.
Leukemia|March 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemiaLoïc Vasseur, Matthieu Duchmann, Nicolas Duployez, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Blood|April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasmsAnouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
NEJM Evidence|June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML TherapyMathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
Pageof 6